Characterization and detection of artificial replication-competent lentivirus of altered host range

Molecular Therapy

Volumn 8, Issue 1, 2003, Pages 118-129

  Segall, Harry I ^a   Yoo, Eunsun ^a   Sutton, Richard E ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; LENTIVIRUS VECTOR;

ARTICLE; ASSAY; CELL DEATH; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HOMOLOGOUS RECOMBINATION; HOST RANGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INOCULATION; LENTIVIRINAE; NONHUMAN; PROVIRUS; TARGET CELL; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS DETECTION; VIRUS ENVELOPE; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0041698407     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00134-5     Document Type: Article

References (76)

1. Bainbridge, J. W., et al. (2001). In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector: Efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther. 8: 1665-1668.
2. Bieniasz, P. D., and Cullen, B. R. (2000). Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J. Virol. 74: 9868-9877.
3. Bourinbaiar, A. S. (1994). The ratio of defective HIV-1 particles to replication-competent infectious virions. Acta Virol. 38: 59-61.
4. Buchschacher, G. L., and Wong-Staal, F. (2000). Development of lentiviral vectors for gene therapy for human diseases. Blood 95: 2499-2504.
5. Bukrinsky, M. I., et al. (1993). A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365: 666-669.
6. Chen, W., et al. (2000). Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells 18: 352-359.
7. Chong, H., Starkey, W., and Vile, R. G. (1998). A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J. Virol. 72: 2663-2670.
8. Chong, H., and Vile, R. G. (1996). Replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line. Gene Ther. 3: 624-629.
9. Cisterni, C., Henderson, C. E., Aebischer, P., Pettmann, B., and Deglon, N. (2000). Efficient gene transfer and expression of biologically active glial cell line-derived neurotrophic factor in rat motoneurons transduced with lentiviral vectors. J. Neurochem. 74: 1820-1828.
10. Cohen, J. (2001). Building a small-animal model for AIDS, block by block. Science 293: 1034-1036.
11. Dull, T., et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463-8471.
12. Ehrengruber, M. U., Hennou, S., Bueler, H., Naim, H. Y., Deglon, N., and Lundstrom, K. (2001). Gene transfer into neurons from hippocampal slices: Comparison of recombinant Semliki Forest virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol. Cell. Neurosci. 17: 855-871.
13. Fleming, J., Ginn, S. L., Weinberger, R. P., Trahair, T. N., Smythe, J. A., and Alexander, I. E. (2001). Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons. Hum. Gene Ther. 12: 77-86.
14. Follenzi, A., Ailles, L. E., Bakovic, S., Geuna, M., and Naldini, L. (2000). Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25: 217-222.
15. Forestell, S. P., Dando, J. S., Bohnlein, E., and Rigg, R. J. (1996). Improved detection of replication-competent retrovirus. J. Virol. Methods 60: 171-178.
16. Forget, J., Yao, X. J., Mercier, J., and Cohen, E. A. (1998). Human immunodeficiency virus type 1 vpr protein transactivation function: Mechanism and identification of domains involved. J. Mol. Biol. 284: 915-923.
17. Fuller, M., and Anson, D. S. (2001). Helper plasmids for production of HIV-1-derived vectors. Hum. Gene Ther. 12: 2081-2093.
18. Galileo, D. S., Hunter, K., and Smith, S. B. (1999). Stable and efficient gene transfer into the mutant retinal pigment epithelial cells of the Mitf(vit) mouse using a lentiviral vector. Curr. Eye Res. 18: 135-142.
19. Gallardo, H. F., Tan, C., Ory, D., and Sadelain, M. (1997). Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90: 952-957.
20. Garrett, E., Miller, A. R., Goldman, J. M., Apperley, J. F., and Melo, J. V. (2000). Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line. Virology 266: 170-179.
21. Gasmi, M., Glynn, J., Jin, M. J., Jolly, D. J., Yee, J. K., and Chen, S. T. (1999). Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J. Virol. 73: 1828-1834.
22. Goh, W. C., et al. (1998). HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nat Med. 4: 65-71.
23. Gorry, P. R., et al. (1999). Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and net mRNAs despite efficient expression of Tat and Rev. J. Virol. 73: 352-361.
24. Hall, M. P., Burson, K. K., and Huestis, W. H. (1998). Interactions of a vesicular stomatitis virus G protein fragment with phosphatidylserine: NMR and fluorescence studies. Biochim. Biophys. Acta 1415: 101-113.
25. He, J., Choe, S., Walker, R., Di Marzio, P., Morgan, D. O., and Landau, N. R. (1995). Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69: 6705-6711.
26. Higashikawa, F., and Chang, L. (2001). Kinetic analyses of stability of simple and complex retroviral vectors. Virology 280: 124-131.
27. Jobbagy, Z., Garfield, S., Baptiste, L., Eiden, M. V., and Anderson, W. B. (2000). Subcellular redistribution of Pit-2 P(i) transporter/amphotropic leukemia virus (A-MuLV) receptor in A-MuLV-infected NIH 3T3 fibroblasts: Involvement in superinfection interference. J. Virol. 74: 2847-2854.
28. Jowett, J. B., Planelles, V., Poon, B., Shah, N. P., Chen, M. L., and Chen, I. S. (1995). The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69: 6304-6313.
29. Kafri, T., Blomer, U., Peterson, D. A., Gage, F. H., and Verma, I. M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17: 314-317.
30. Kafri, T., Van Praag, H., Ouyang, L., Gage, F. H., and Verma, I. M. (1999). A packaging cell line for lentivirus vectors. J. Virol. 73: 576-584.
31. Kim, V. N., Mitrophanous, K., Kingsman, S. M., and Kingsman, A. J. (1998). Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72: 811-816.
32. Kotsopoulou, E., Kim, V. N., Kingsman, A. J., Kingsman, S. M., and Mitrophanous, K. A. (2000). A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 74: 4839-4852.
33. Landau, N. R., and Littman, D. R. (1992). Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66: 5110-5113.
34. Lewis, P., Hensel, M., and Emerman, M. (1992). Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11: 3053-3058.
35. Lewis, P. F., and Emerman, M. (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol. 68: 510-516.
36. Li, C. J., Friedman, D. J., Wang, C., Metelev, V., and Pardee, A. B. (1995). Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268: 429-431.
37. Liu, M. L., Winther, B. L., and Kay, M. A. (1996). Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: Comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J. Virol. 70: 2497-2502.
38. Mahalingam, S., Ayyavoo, V., Patel, M., Kieber-Emmons, T., and Weiner, D. B. (1997). Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol. 71: 6339-6347.
39. Mariani, R., Kirchhoff, F., Greenough, T. C., Sullivan, J. L., Desrosiers, R. C., and Skowronski, J. (1996). High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J. Virol. 70: 7752-7764.
40. Mariani, R., Rutter, G., Harris, M. E., Hope, T. J., Krausslich, H. G., and Landau, N. R. (2000). A block to human immunodeficiency virus type 1 assembly in murine cells. J. Virol. 74: 3859-3870.
41. Martinez, I., and Dornburg, R. (1996). Partial reconstitution of a replication-competent retrovirus in helper cells with partial overlaps between vector and helper cell genomes. Hum. Gene Ther. 7: 705-712.
42. Miyoshi, H., Blomer, U., Takahashi, M., Gage, F. H., and Verma, I. M. (1998). Development of a self-inactivating lentivirus vector. J. Virol. 72: 8150-8157.
43. Miyoshi, H., Takahashi, M., Gage, F. H., and Verma, I. M. (1997). Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA 94: 10319-10323.
44. Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93: 11382-11388.
45. Naldini, L., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
46. Ory, D. S., Neugeboren, B. A., and Mulligan, R. C. (1996). A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci, USA 93: 11400-11406.
47. Otto, E., et al. (1994). Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences. Hum. Gene Ther. 5: 567-575.
48. Park, F., Ohashi, K., and Kay, M. A. (2000). Therapeutic levels of human factor VIII and IX using HIV-1 -based lentiviral vectors in mouse liver. Blood 96: 1173-1176.
49. Pfeifer, A., et al. (2001). Transduction of liver cells by lentiviral vectors: Analysis in living animals by fluorescence imaging. Mol. Ther. 3: 319-322.
50. Poeschla, E., Corbeau, P., and Wong-Staal, F. (1996). Development of HIV vectors for anti-HIV gene therapy. Proc. Natl. Acad. Sci. USA 93: 11395-11399.
51. Poznansky, M., Lever, A., Bergeron, L., Haseltine, W., and Sodroski, J. (1991). Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector. J. Virol. 65: 532-536.
52. Premkumar, D. R., et al. (1996). The nef gene from a long-term HIV type 1 nonprogressor. AIDS Res. Hum. Retroviruses 12: 337-345.
53. Printz, M., Reynolds, J., Mento, S. J., Jolly, D., Kowal, K., and Sajjadi, N. (1995). Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays. Gene Ther. 2: 143-150.
54. Purvis, S. F., Jacobberger, J. W., Sramkoski, R. M., Patki, A. H., and Lederman, M. M. (1995). HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res. Hum. Retroviruses 11: 443-450.
55. Rebolledo, M. A., Krogstad, P., Chen, F., Shannon, K. M., and Klitzner, T. S. (1998). Infection of human fetal cardiac myocytes by a human immunodeficiency virus-1-derived vector. Circ. Res. 83: 738-742.
56. Richardson, J. H., Kaye, J. F., Child, L. A., and Lever, A. M. (1995). Helper virus-free transfer of human immunodeficiency virus type 1 vectors. J. Gen. Virol. 76: 691-696.
57. Roe, T., Reynolds, T. C., Yu, G., and Brown, P. O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12: 2099-2108.
58. Sakoda, T., Kasahara, N., Hamamori, Y., and Kedes, L. (1999). A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes. J. Mol. Cell. Cardiol. 31: 2037-2047.
59. Salvi, R., Garbuglia, A. R., Di Caro, A., Pulciani, S., Montella, F., and Benedetto, A. (1998). Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor. J. Virol. 72: 3646-3657.
60. Schlegel, R., Tralka, T. S., Willingham, M. C., and Pastan, I. (1983). Inhibition of VSV binding and infectivity by phosphatidylserine: Is phosphatidylserine a VSV-binding site? Cell 32: 639-646.
61. Sutton, R. E., and Littman, D. R. (1996). Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J. Virol. 70: 7322-7326.
62. Sutton, R. E., Reitsma, M. J., Uchida, N., and Brown, P. O. (1999). Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J. Virol. 73: 3649-3660.
63. Sutton, R. E., Wu, H. T., Rigg, R., Bohnlein, E., and Brown, P. O. (1998). Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72: 5781-5788.
64. Trono, D. (2000). Lentiviral vectors: Turning a deadly foe into a therapeutic agent. Gene Ther. 7: 20-23.
65. Uchida, N., et al. (1998). HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95: 11939-11944.
66. Vanitharani, R., et al. (2001). HIV-1 Vpr transactivates LTR-directed expression through sequences present within - 278 to - 176 and increases virus replication in vitro. Virology 289: 334-342.
67. Wagner, R., et al. (2000). Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: Implications for the safety of lentiviral vectors. Hum. Gene Ther. 11: 2403-2413.
68. Woods, N. B., Mikkola, H., Nilsson, E., Olsson, K., Trono, D., and Karlsson, S. (2001). Lentiviral-mediated gene transfer into haematopoietic stem cells. J. Intern. Med. 249: 339-343.
69. Wu, X., et al. (2000). Development of a novel trans-lentiviral vector that affords predictable safety. Mol. Ther. 2: 47-55.
70. Xu, K., Ma, H., Mccown, T. J., Verma, I. M., and Kafri, T. (2001). Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol. Ther. 3: 97-104.
71. Yamada, S., and Ohnishi, S. (1986). Vesicular stomatitis virus binds and fuses with phospholipid domain in target cell membranes. Biochemistry 25: 3703-3708.
72. Yamada, T., and Iwamoto, A. (2000). Comparison of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection. Arch. Virol. 145: 1021-1027.
73. Yao, X. J., et al. (1998). Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells. J. Virol. 72: 4686-4693.
74. Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., and Charneau, P. (2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101: 173-185.
75. Zufferey, R., et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72: 9873-9880.
76. Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., and Trono, D. (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15: 871-875.